Xcovery Holdings, Inc. (Xcovery), an evidence-based, innovation-driven pharmaceutical company, today announced an agreement ...

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over ...

With the ink barely dry on an agreement to buy Kelonia, Eli Lilly has signed a deal to take ownership of Ajax Therapeutics ...

Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema ...

After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for ...

Lilly is emphasising that Foundayo can be taken any time of day, without food or water restrictions, while Wegovy has to be ...

The launch of a new national research collaboration focused on Parkinson’s disease has been announced. The Parkinson’s ...

Inizio Ignite reshuffles leadership as advisory model evolves. Inizio Ignite, a fully integrated advisory partner, announced ...

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater. With nearly ...

Moreover, it requires quick strategic thinking and often agile investment attitudes." The transformation of pharmaceutical ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...